✦ LIBER ✦

Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0–2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance?

✍ Scribed by John F. Ward; George Bartsch; Thomas J. Sebo; Germar-Michael Pinggera; Michael L. Blute; Horst Zincke

Book ID: 117724311
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 227 KB
Volume: 22
Category: Article
ISSN: 1078-1439
DOI: 10.1016/s1078-1439(03)00093-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1459 CLINICAL AND PATHOLOGIC FEATURES OF

1459 CLINICAL AND PATHOLOGIC FEATURES OF PROSTATE CANCER WITH PROSTATIC-SPECIFIC ANTIGEN (PSA) LESS THAN 2.5 NG/ML: A STUDY OF 209 CASES

✍ Trinh, Quoc-Dien; Ghani, Khurshid R.; Roquero, Leonardo; Jeong, Wooju; Kryvenko, 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 46 KB

Re: Predictors of Subsequent Prostate Ca

Re: Predictors of Subsequent Prostate Cancer in Men with a Prostate-Specific Antigen (PSA) of 2.6 to 4.0 ng/mL and an Initially Negative Biopsy

✍ Fritz H. Schröder 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 65 KB

PD-01.01: Even in low PSA ranges (0-2.5

PD-01.01: Even in low PSA ranges (0-2.5 ng/ml/cc) the PSA density of the transition zone is a very significant adjunct to serum PSA in differentiating prostate cancer from benign disease

✍ V. Scattoni; T. Ben Addi; P. Hoffman; C.C. Schulman; P. Rigatti; F. Montorsi; A. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Prostate-Specific Antigen (PSA) Isoform

Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting

✍ Giorgio Guazzoni; Luciano Nava; Massimo Lazzeri; Vincenzo Scattoni; Giovanni Lug 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 473 KB

THE INCIDENCE OF PROSTATE CANCER IN A SC

THE INCIDENCE OF PROSTATE CANCER IN A SCREENING POPULATION WITH A SERUM PROSTATE SPECIFIC ANTIGEN BETWEEN 2.5 AND 4.0 NG./ML.: RELATION TO BIOPSY STRATEGY

✍ BABAIAN, RICHARD J.; JOHNSTON, DENNIS A.; NACCARATO, WILLIAM; AYALA, ALBERTO; BH 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 71 KB

Free-to-total prostate-specific antigen

Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1–10.0 ng/ml as a criterion

✍ Yoshitomo Kobori; Yasuhide Kitagawa; Atsushi Mizokami; Kazuto Komatsu; Mikio Nam 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 255 KB